43 results
424B5
NNVC
NanoViricides Inc
4 Aug 23
Prospectus supplement for primary offering
5:54pm
of bio-defense drugs through NIH funding, the review process by the FDA and the final government procurement contracting authority. While this may
424B5
w6bczj 87ep9q0
31 Jul 20
Prospectus supplement for primary offering
5:29pm
424B5
x00fttzq
9 Jul 20
Prospectus supplement for primary offering
5:13pm
424B5
7gpz4ub49fran
8 Jul 20
Prospectus supplement for primary offering
9:57pm
424B5
45189
21 May 20
Prospectus supplement for primary offering
9:21pm
424B1
oe2v32fbz4hch5
23 Jan 20
Prospectus with pricing info
9:04pm
S-1
npvlnn xxyg4xcewm8
28 Sep 19
IPO registration
3:07am
424B5
rxudvx 50o6zb
1 Mar 19
Prospectus supplement for primary offering
12:00am